# The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension

Study · id `cardio:ct-nct03614260` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03614260](<https://clinicaltrials.gov/study/NCT03614260>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03614260

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 224 participants.

## Technical summary

Registry record NCT03614260. Randomized; double masking; primary purpose treatment. Start 2018-12-14 (actual); primary completion 2022-12-21 (actual). Results posted on 2026-09-24.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 224 participants (enrolled count; ClinicalTrials.gov record NCT03614260, source copy `cardio:ctgov-nct03614260-2026-09-24`, retrieved 2026-10-26)
- Started: 2018-12-14 (actual) (ClinicalTrials.gov record NCT03614260, source copy `cardio:ctgov-nct03614260-2026-09-24`, retrieved 2026-10-26)
- Primary completion: 2022-12-21 (actual) (ClinicalTrials.gov record NCT03614260, source copy `cardio:ctgov-nct03614260-2026-09-24`, retrieved 2026-10-26)
- Completion: 2029-07 (anticipated) (ClinicalTrials.gov record NCT03614260, source copy `cardio:ctgov-nct03614260-2026-09-24`, retrieved 2026-10-26)
- Results first posted: 2026-09-24 (ClinicalTrials.gov record NCT03614260, source copy `cardio:ctgov-nct03614260-2026-09-24`, retrieved 2026-10-26)
- Countries: United States; Belgium; France; Germany; Ireland; Netherlands; Switzerland; United Kingdom (ClinicalTrials.gov record NCT03614260, source copy `cardio:ctgov-nct03614260-2026-09-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03614260-2026-09-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension
- Acronym: RADIANCE-II
- Condition: Hypertension
- Condition: Vascular Diseases
- Condition: Cardiovascular Diseases
- Intervention (Device): Paradise Renal Denervation System
- Intervention (Procedure): Renal Angiogram
- Lead sponsor: ReCor Medical, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: ReCor Medical, Inc. (`cardio:org-recor-medical-inc`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: Endovascular Ultrasound Renal Denervation to Treat Hypertension: The RADIANCE II Randomized Clinical Trial (`cardio:pubmed-36853250`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 5efdd4fa1fc2e79a0487249d3ee0e925fc46f2c46d5f0343d58b68ed2a8cdc72
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
